The Latest Breaking News from FDA

Risks of a wave are compounded by new vaccine restrictions from the Trump administration

The Food and Drug Administration has heightened concerns over a nationwide butter recall, escalating the risk level after discovering the presence of an undeclared major allergen.

When a product is recalled, there is an official announcement from the manufacturer and a government agency like the CPSC or the FDA. However, sometimes a product disappears from store shelves suddenly and quietly, with no recall notice to explain its absence. This “silent discontinuation” often happens when a product…

On Monday, Replimune Group Inc. (NASDAQ:REPL) is reeling after the FDA unexpectedly rejected its skin cancer treatment, triggering a stock plunge and a wave of investor outrage.

Keeping your home clean is important. You want to trust the cleaning products you buy. But what if some of those products lost their FDA approval and are still on store shelves? This isn’t just about following rules. It’s about your health and safety. Some products may not work as…

Bunge's butter recall hits Class II warning after milk allergen left off label, spotlighting FDA oversight and labelling requirements.

Open almost any bathroom cabinet in America, and you’re likely to find a few bottles of forgotten pills. Maybe they were prescribed years ago for...

Trendy foods come and go, but some leave a bigger mark than others. Sometimes, a food gets so popular that it’s everywhere—until it suddenly disappears. Why? Because some trendy foods end up getting banned. This can happen for health reasons, environmental concerns, or even legal issues. If you care about…

When a product gets banned, it often makes headlines. Whether it’s due to health concerns, political controversy, or public backlash, banned items tend to stir up emotions—and disappear overnight. But not all bans last forever. Over time, some items are quietly reformulated, relabeled, or simply reintroduced with little fanfare. Here…

The recalled fruit was sold at Sam’s Club stores in 42 states

The U.S. Food and Drug Administration approved on Friday, the Novo Nordisk A/S (NYSE:NVO) Alhemo (concizumab-mtci) injection as a once-daily prophylaxis to prevent or reduce the frequency of bleeding episodes in patients 12 years of age and older with hemophilia A or B without inhibitors.